Xue Ke

1.1k total citations
34 papers, 885 citations indexed

About

Xue Ke is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Xue Ke has authored 34 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Biomaterials and 9 papers in Pharmaceutical Science. Recurrent topics in Xue Ke's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Drug Solubulity and Delivery Systems (6 papers). Xue Ke is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Drug Solubulity and Delivery Systems (6 papers). Xue Ke collaborates with scholars based in China, United States and Norway. Xue Ke's co-authors include Tianyuan Ci, Hao Wu, Haifeng Sun, Dinglingge Cao, Yi Chen, Jilai Tian, Danrong Hu, Yueyang Deng, Haohuan Li and Xingxian Zhang and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Acta Biomaterialia.

In The Last Decade

Xue Ke

32 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Ke China 17 354 318 314 132 90 34 885
Kaushik Kuche India 19 389 1.1× 424 1.3× 267 0.9× 182 1.4× 125 1.4× 41 1.1k
Shuangquan Gou China 19 380 1.1× 294 0.9× 381 1.2× 159 1.2× 121 1.3× 30 1.1k
Diana Guimarães Portugal 7 373 1.1× 470 1.5× 260 0.8× 181 1.4× 85 0.9× 12 1.0k
Marcela Tavares Luiz Brazil 18 434 1.2× 364 1.1× 359 1.1× 188 1.4× 110 1.2× 44 1.0k
Sohee Son South Korea 18 369 1.0× 743 2.3× 301 1.0× 189 1.4× 111 1.2× 44 1.4k
Roghiyeh Pashaei‐Asl Iran 8 261 0.7× 466 1.5× 244 0.8× 76 0.6× 147 1.6× 15 1.0k
Somayeh Handali Iran 15 372 1.1× 275 0.9× 226 0.7× 146 1.1× 55 0.6× 28 735
Hassan Shah Pakistan 15 404 1.1× 305 1.0× 307 1.0× 255 1.9× 77 0.9× 29 894
Sri Vishnu Kiran Rompicharla India 18 325 0.9× 339 1.1× 223 0.7× 147 1.1× 89 1.0× 25 821

Countries citing papers authored by Xue Ke

Since Specialization
Citations

This map shows the geographic impact of Xue Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Ke more than expected).

Fields of papers citing papers by Xue Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Ke. The network helps show where Xue Ke may publish in the future.

Co-authorship network of co-authors of Xue Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Ke. A scholar is included among the top collaborators of Xue Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Ke. Xue Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ke, Xue, et al.. (2024). CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma. International Journal of Biological Macromolecules. 267(Pt 2). 130915–130915. 9 indexed citations
2.
Wang, Peiwen, Feng Zhi, Yufang Tang, et al.. (2023). Oroxylin a promoted apoptotic extracellular vesicles transfer of glycolytic kinases to remodel immune microenvironment in hepatocellular carcinoma model. European Journal of Pharmacology. 957. 176037–176037. 9 indexed citations
3.
Guo, Yongjian, Yuening Sun, Wenjing Guo, et al.. (2023). Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy. Biomedicine & Pharmacotherapy. 166. 115342–115342. 3 indexed citations
4.
Zhao, Hui, Chenhong Zhu, Chenchen Li, et al.. (2023). Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma. Biomedicine & Pharmacotherapy. 165. 115096–115096. 10 indexed citations
5.
Chen, Mo, et al.. (2022). Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia. Journal of Nanobiotechnology. 20(1). 273–273. 32 indexed citations
6.
Wu, Hao, et al.. (2020). Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors. International Journal of Biological Macromolecules. 164. 2583–2597. 45 indexed citations
7.
Gan, Yanxiong, Dengqiu Xu, Hongjuan Zhang, et al.. (2020). Evaluating supersaturation in vitro and predicting its performance in vivo with Biphasic gastrointestinal Simulator: A case study of a BCS IIB drug. International Journal of Pharmaceutics. 578. 119043–119043. 9 indexed citations
8.
Chen, Mo, et al.. (2019). Liquid jet breakup: A new method for the preparation of poly lactic-co-glycolic acid microspheres. European Journal of Pharmaceutics and Biopharmaceutics. 137. 140–147. 9 indexed citations
9.
Wang, Jianping, et al.. (2019). In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate. Biomaterials. 217. 119296–119296. 42 indexed citations
10.
Sun, Haifeng, Dinglingge Cao, Hao Wu, et al.. (2018). Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy. International Journal of Biological Macromolecules. 112. 343–355. 36 indexed citations
11.
Deng, Yueyang, et al.. (2017). Different effects of silica added internal or external on in vitro dissolution of indomethacin hot-melt extrudates. International Journal of Pharmaceutics. 534(1-2). 272–278. 6 indexed citations
12.
Chen, Yi, Haohuan Li, Yueyang Deng, et al.. (2017). Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment. Acta Biomaterialia. 51. 374–392. 95 indexed citations
13.
Hu, Danrong, et al.. (2016). GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy. International Journal of Nanomedicine. Volume 11. 5125–5147. 54 indexed citations
14.
Qi, Rong, Cong Chen, Lu Xu, et al.. (2015). G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Journal of Controlled Release. 210. 160–168. 40 indexed citations
15.
Chen, Yi, Jianqing Peng, Miaomiao Han, et al.. (2014). A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis. Journal of drug targeting. 23(4). 335–346. 31 indexed citations
16.
Tian, Jilai, Lu Wang, Lei Wang, & Xue Ke. (2013). A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects. Drug Delivery. 21(7). 553–559. 49 indexed citations
17.
Li, Jie, et al.. (2012). The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid. Journal of drug targeting. 20(5). 467–473. 35 indexed citations
18.
Ke, Xue, et al.. (2011). The microstructure characterization of meloxicam microemulsion and its influence on the solubilization capacity. Drug Development and Industrial Pharmacy. 37(8). 894–900. 26 indexed citations
19.
Ke, Xue, Qineng Ping, & Zheng‐Gen Liao. (2006). Interconversion Kinetic Studies of Betamethasone Acetate Polymorphs in Water. Drug Development and Industrial Pharmacy. 32(9). 1019–1024. 2 indexed citations
20.
Ke, Xue, et al.. (2005). Interconversion Studies of Betamethasone Acetate Polymorphs. Drug Development and Industrial Pharmacy. 31(8). 813–818. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaushik Kuche Breakdown of academic impact, for papers by Shuangquan Gou Breakdown of academic impact, for papers by Diana Guimarães Breakdown of academic impact, for papers by Marcela Tavares Luiz Breakdown of academic impact, for papers by Sohee Son Breakdown of academic impact, for papers by Roghiyeh Pashaei‐Asl Breakdown of academic impact, for papers by Somayeh Handali Breakdown of academic impact, for papers by Hassan Shah Breakdown of academic impact, for papers by Sri Vishnu Kiran Rompicharla
Rankless by CCL
2026